Inventiva SA (IVA)
Inventiva annonce l’exercice intégral de l’Option des Banques portant le montant de lOffre à environ 172,5 millions de dollars
Inventiva annonce l’exercice intégral de l’Option des Banques portant le montant de lOffre à environ 172,5 millions de dollars
Inventiva announces full exercise of Underwriters’ Option, bringing proceeds of Offering to approximately $172.5M
Incyte Announces Positive CHMP Opinion for Minjuvi®(tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma (FL)
Innate Pharma - Innate Pharma to Present at Jefferies Global Healthcare Conference
Innate Pharma to Present at Jefferies Global Healthcare Conference
Cordlife Group Limited - Announcement
ABBIE and CAR-T: A Powerful Combo for Safer Cancer Therapies
Mersana Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Mersana Therapeutics, Inc. - MRSN
Cidara Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cidara Therapeutics, Inc. - CDTX
Fresenius Medical Care places bond with a volume of 500 million Euros